In contrast to adult lymphocytes, neonatal lymphocytes secrete minimal amounts of Ig in response to stimulation with immobilized MAb to CD3. This deficiency could be overcome by the addition of supplemental IL-2, IL4, or IL-6, resulting in the secretion of all Ig isotypes. There were no major differences in the distribution of Ig isotypes secreted in response to the cytokines alone or in combination. The Ig secreted in response to 114 or IL-6 was inhibited by MAb to CD25, suggesting that the effects of IL4 and IL-6 were dependent on IL-2. Stimulation of neonatal lymphocytes with anti-CD3 was sufficient to induce expression of IL-2 receptors (CD25) on both T and B cells. I1-4 exerted direct effects on neonatal T cells by increasing IL-2 production and promoting IL-6 production by anti-CD3-stimulated neonatal lymphocytes. Antibody to IL-4 or IL-6 did not inhibit Ig secretion in response to IL-2 and antibody to IL-6 did not consistently inhibit Ig secretion in response to IL-4. Finally, in the presence of cyclosporin, anti-CD3-stimulated neonatal lymphocytes secreted Ig only with the combination of IL-2 and IL4. These results have delineated unique, but not Ig isotype-specific, effects of cytokines in supporting Ig secretion by anti-CD3-stimulated neonatal lymphocytes. Deficient production of these cytokines is likely to contribute to the decreased capacity of neonatal lymphocytes to generate an Ig response. (J. Clin. Invest. 1991. 88:967-977.) Key words: interleukin 4 * interleukin 2 * interleukin 6 * CD3 -cyclosporin
Introduction
Neonates are deficient in their ability to produce Ig (1) . In vitro studies have demonstrated deficiencies in both T and B cell function (2, 3) . Previous studies employing immobilized anti-CD3 MAb, a powerful stimulus for Ig secretion by adult lymphocytes, demonstrated that neonatal B and T cells were unable to produce Ig of any isotype (4) . Neonatal lymphocytes could be induced to secrete Ig in response to anti-CD3 stimulation if exogenous cytokines in the form of supernatants from mitogen-activated adult T cells were supplied. These results suggested that either cytokine production by neonatal lymphocytes is functionally deficient or that neonatal lymphocytes are 1 . Abbreviation used in this paper: PE, phycoerythrin. less responsive to cytokines. The current studies were designed to examine these issues and focused on the roles of IL-2, IL-4, IL-6, and IFN-'y in the regulation of the capacity of neonatal lymphocytes to produce 1g.
IL-4 has important regulatory effects on both T and B cell differentiation and may be important in the regulation of Ig isotype switch (5) (6) (7) (8) (9) . Moreover, naive T cells are deficient in their ability to produce IL-4 (10-13). IFN-y is also reported to play an important regulatory role in Ig isotype switching (14, 15) and production of this cytokine by naive T cells is also reported to be deficient (16, 17) . IL-6 promotes T cell activation and Ig production by B cells (18) (19) (20) . However, the importance of this cytokine in the enhancement of Ig production by naive B and T cells has not been well characterized. Therefore, the ability of these cytokines to promote Ig secretion and to influence the Ig isotypes secreted by anti-CD3-stimulated neonatal lymphocytes was investigated.
The results demonstrate that IL-2 is essential for the differentiation of neonatal B cells but that IL-4 and IL-6 also promote Ig secretion by neonatal B and T cells. The complex interplay of these cytokines appears to determine the magnitude of the antibody response of anti-CD3-activated neonatal lymphocytes. Although minor differences in the Ig heavy-chain isotypes secreted in response to the various cytokines were noted, no cytokine specific effects on the pattern of secreted Ig isotypes were demonstrated.
generously provided by Dr. T. Waldmann, National Cancer Institute, National Institutes of Health (25) . Anti-CD25 conjugated to phycoerythrin (PE) and anti-CD20-fluorescein isothiocyanate (FITC) were purchased from Becton, Dickinson & Co., San Jose, CA. 2H4 (Coulter Immunology, Hialeah, FL) is an IgGI antibody to the CD45RA molecule (26) . Rabbit antibody to human IL-6 was obtained from Amgen Biologicals and diluted 1: 150 to neutralize 40 ng/ml of IL-6. 8F-12, an IgGI, MAb to human IL-4 was the kind gift of Dr. C. H. Heusser, Basel, Switzerland (10) .
Cell separation. PBMC from adult peripheral blood and cord blood were depleted ofmonocytes and natural killer (NK) cells by incubation with 5 mM L-leucine methyl ester (Sigma Chemical Co.) in serum-free medium (27, 28) . After washing, B cells were depleted ofT cells by two cycles of rosetting with neuraminidase-treated sheep red blood cells (29) . Adult B cells prepared in this fashion are > 90% CD20 positive, as has been previously established (30) . Cord blood B cells were 70-75% CD20 positive, and 75-90% CD19 positive. Approximately 85-90% of both the cord and adult CD20-positive cells stained positively for IgD. The B cell preparations contained < 1% CD3-positive cells. Sedimented rosette-forming cells from the first centrifugation were treated with isotonic NH4C1 to lyse the sheep RBC. Adult and cord blood T cell populations were > 95% CD3+. T cells were subjected to 2,000 rad of y-irradiation before culture. Culture conditions. 64.1 was diluted in 0.05 M Tris, pH 9.5, the concentration was adjusted to 4 gg/ml, and 50 ,d were placed in each of the wells of 96-well microtiter plates (Costar, Cambridge, MA) and incubated at room temperature for 1-5 h. Afterward, the wells were washed twice with medium to remove nonadherent MAb before the addition ofcells (31) . Routine cultures were carried out in triplicate in a total volume of 200 ,ul per well. T cells were added at a density of 1.0
x 10' per well and B cells were added at 2.5 X 104 per well unless indicated otherwise. The cultures were incubated at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Supernatants for quantitation of Ig secretion were harvested at varying time points as indicated.
Measurement of Ig secretion. Ig in the culture supernatants was quantitated utilizing isotype-specific ELISAs as previously described (7, 32) . The sensitivities of the specific assays are as follows: IgM, 24 ng/ml; IgG and IgA, 12 ng/ml. IgG subclass production was determined utilizing purified mouse IgG MAb to human IgG subclasses, (IgGl-JDC 1, IgG4-JDC 14, Southern Biotechnology Associates, Birmingham, AL; IgG2-HP6014, IgG3-HP6047, American Type Culture Collection, Rockville, MD) bound to microtiter plates coated with goat anti-mouse IgG Fc fragment (Cappel Laboratories, Cooper Biochemical, Malvern, PA) as previously described (7, 33) . Bound IgG was detected with peroxidase-conjugated affinity-purified goat anti-human IgG (Tago, Inc., Burlingame, CA) and compared to serial dilutions of purified myeloma IgG subclass standards, a kind gift of Dr. Hans Spiegelberg, La Jolla, CA. The sensitivity of the IgG subclass assays is 12 ng/ml. IL-2 assay. Supernatants to be assayed for IL-2 production were obtained after incubation ofneonatal T cells (1.0 x 105 per well) for 72 h with immobilized anti-CD3 in the presence of 5 jg/ml anti-CD25. Supernatants were filtered and frozen before assay. IL-2 production was determined by incubation of CTLL cells (5 X IL-6 assay. IL-6 in the culture supernatants was quantitated utilizing an immunoassay specific for human IL-6 (Amgen Diagnostics, Thousand Oaks, CA) the sensitivity ofthe assay is 10 pg/ml. This assay is specific for IL-6.
Immunofluorescence analysis. B cells (1 x 106) and T cells (1 x 106) were incubated with immobilized anti-CD3 in 1 ml of medium with or without cytokines in 16-mm flat-bottomed polystyrene plates (Corning Glass, Inc., Corning, NY). Cells were harvested and stained simultaneously with anti-CD20-FITC to distinguish B cell populations and anti-CD25-PE and fixed with 1% paraformaldehyde. Immunofluorescence was analyzed with the fluorescence-activated cell sorter. Expression of CD45RA was investigated after incubation of neonatal T cells (2 x 106) with immobilized anti-CD3 in 16-mm wells with or without cytokines. Cells were harvested after varied periods of incubation, stained with anti-CD45RA or control antibody, fixed, and analyzed with the fluorescence-activated cell sorter (Becton, Dickinson & Co., Mountain View, CA).
Statistics. The Wilcoxon signed rank test or paired t test was utilized to determine the significance of differences between paired samples.
Results
Ig secretion by anti-CD3-stimulated adult lymphocytes. The Ig secreted by anti-CD3-stimulated adult lymphocytes is detailed in Table I . Anti-CD3 stimulation alone results in the secretion of large amounts of IgM, IgG 1, and IgA. However, production ofall Ig isotypes including substantial amounts ofIgE were also observed. Supplementation ofthese cultures with IL-2, IL-4, or IL-6 had no major effect on the amounts of the various Ig isotypes secreted, except for IgE which was increased by the addition of IL-2 or IL-4. Addition ofcombinations of the cytokines had no additional effects beyond that noted with the addition of IL-2 or IL-4 alone (data not shown). These results suggest that anti-CD3 stimulation alone was sufficient to stimulate large amounts of Ig secretion by the adult lymphocytes and that with the exception ofIgE supplemental cytokines were not required. Induction ofIg secretion by anti-CD3-stimulated neonatal B and T cells with supplemental cytokines. We previously reported that anti-CD3 stimulation was not sufficient to induce Ig secretion by neonatal B and T cells. Therefore, the initial experiments examined the influence ofvarious cytokines on Ig production by anti-CD3-stimulated neonatal lymphocytes. For these experiments Ig secretion was assayed at multiple time points over 5-20 d and the maximal levels of the various Ig isotypes determined. In the absence ofsupplemental cytokines, anti-CD3-stimulated neonatal lymphocytes secreted minimal Ig (Fig. 1) The ability ofIL-6 to induce Ig secretion by anti-CD3-stimulated neonatal B and T cells was also examined (Fig. 2 ). IL-6 induced Ig secretion by most (8 of 13 experiments) of the cord T and B cell cultures. There was no difference in the pattern of Ig isotypes secreted in response to IL-6 compared to that secreted in response to IL-2. The combination of IL-2 and IL-6 markedly increased the secretion of all Ig isotypes above that noted with either cytokine alone. In each experiment shown in Fig. 2 , detailed kinetics of Ig production were analyzed. No reproducible differences were noted in the capacity of IL-2 or IL-6 to alter the rate at which any of the secreted Ig isotypes reached maximal amounts (data not shown). Comparison of the Ig isotypes secreted in response to IL-2 and IL-6 vs. IL-2 and IL-4 from paired experiments indicated that the combination of IL-2 and IL-6 resulted in more secreted Ig than the combination of IL-2 and IL-4 but no differences in the Ig isotypes secreted were noted (data not shown). Finally, addition of IL-6 to cultures supported by IL-4 or IL-2 + IL-4 had no consistent effect on the amount of Ig secreted (data not shown).
The effect ofIL-4 and IL-6 on neonatal B cell Ig production is dependent on IL-2. Ig production by adult B cells requires IL-2 (7, 20, 37 (Fig. 3) . In contrast, MAb to IL4 had no effect on the amount ofIg produced in response to IL-2, although it markedly inhibited IL-4-induced Ig secretion (Table III) .
Antibody to the IL-2 receptor also blocked the secretion of Ig in response to IL-6 either alone or in combination with IL-2 (Fig. 4) . In contrast, antibody to IL-6 had no effect on the amount of Ig produced in response to IL-2, although responses induced by IL-6 were completely inhibited (Fig. 5) These results suggested the possibility that IL-4 might indirectly amplify Ig production by neonatal B cells by enhancing production of IL-6. Therefore, the effect ofan antibody to IL-6 on the capacity of IL-4 to promote Ig production was examined. The data in Fig. 5 indicate that antibody to IL-6 had no consistent effect on IL4-supported Ig production. These results indicate that IL4 could enhance IL-6 production by neonatal lymphocytes although this effect is not essential for IL-4 to promote Ig secretion. with or without supplemental cytokines (IL-2, 50 U/ml; IL4, 100 U/mi; IL-6, 10 U/ml) and neutralizing antibody to duction in order to examine the effects of supplemental cytokines in the absence of endogenously produced cytokines (38) .
In the presence of cyclosporin, IL-2 alone was not sufficient to induce Ig secretion ( 
Discussion
Immobilized anti-CD3 is a powerful inducer ofIg secretion by adult lymphocytes (40, 41) . Detailed analysis ofthe Ig secreted by anti-CD3-stimulated adult B and T cells demonstrated the production of all Ig isotypes without supplemental cytokines. Supplemental IL-2, IL-4, or IL-6 did not enhance Ig produc- (10) (11) (12) (13) (14) (15) . Therefore, the capacity of exogenous cytokines to promote Ig production by neonatal lymphocytes was explored. In order to evaluate T cell-B cell collaboration, it was necessary to prevent the suppressive effect of the neonatal T cells by irradiating them, as previously described (4). Irradiation decreased, but did not prevent IL-2 production. However, in contrast to adult cultures, endogenous production of IL-2 was insufficient for the support of Ig production by neonatal B cells. (42, 43) . Of note, the y3 heavy chain is the most 5' ofthe y heavy-chain genes followed by y 1, -y2, and y4, suggesting that the disproportionate increase in IgG3 secretion by the neonatal lymphocytes may be consistent with a tendency to switch from IgM to the most proximal y heavy chain gene (44) . This is not an exclusive switch however, as IgG1 remains the predominant IgG subclass produced and the cells also produce small amounts of IgG2 and IgG4 as well as IgA and IgE.
The current work addressed the possibility that cytokines other than IL-2 may be important for the induction of Ig secretion and for the production of individual Ig isotypes by neonatal lymphocytes. IL-4 has major effects on T cell proliferation as well as regulatory effects on human B cell growth and differentiation (5-7). IL-4 has also been shown to facilitate IgE synthesis and secretion (8, 15, 45, 46 (19, 20) . A recent report suggested that IL-6 was required for primary immunoglobulin responses in the mouse (48) . Previous reports suggest that IL-6 is made by both neonatal T and B cells in response to mitogens (49) . However, two recent reports suggest that production of IL-6 by naive T cells stimulated with anti-CD2 or anti-CD3 may be deficient (13, 50) . Therefore, the action of IL-6 on neonatal Ig production stimulated by anti-CD3 was also investigated. Our previous work suggested that neither IILA or IL-6 alone supported the production ofIg by S. aureus-stimulated adult B cells (6, 7, 20) . Inhibition of the IL4-and IL-6-induced Ig secretion by antibody to CD25 supported the conclusion that A number of effects of IL-4 were documented that could explain its capacity to enhance Ig production by neonatal B cells. First it dramatically increased IL-2 production by anti-CD3-activated neonatal T cells, although it had no effect on IL-2R expression by either neonatal T or B cells. This effect on IL-2 production is consistent with a previous report showing that IL-4 enhanced IL-2 production by mitogen-stimulated adult T cells (5) . IL-4 exerted other effects in this model system that also contributed to its capacity to enhance Ig production. Thus, for example, the presence of IL-4 during activation of neonatal T cells with anti-CD3 enhanced the subsequent ability ofthe activated neonatal T cells to support neonatal B cell Ig secretion independently of effects on cytokine production.
These results support the conclusion that IL-4 directly enhanced the capacity ofactivated neonatal T cells to collaborate with B cells as well as produce cytokines necessary for B cell differentiation. IL-4 also enhanced production of IL-6 by neonatal lymphocytes. This was particularly noteworthy in co-cultures ofanti-CD3-activated neonatal T and B cells. The cell of origin of the IL-6 was not determined in these mixed cell cultures. It is clear that IL-4 can augment IL-6 production by anti-CD3-activated neonatal T cells but in the mixed cultures IL-4 could have amplified IL-6 production from B cells as well.
In this regard, a recent report suggests that IL-4 may directly promote IL-6 production by resting purified adult human B cells (51) . For the current studies, the important finding was that even though IL-4 induced IL-6 production from neonatal lymphocytes, the induction of IL-6 production could not account for the effects ofIL-4 on anti-CD3-stimulated Ig production by neonatal lymphocytes. Thus neonatal T-B cell interactions independently of its effects on cytokine production. IL-4 has been reported to promote conjugate formation between murine T cells and B cells and to enhance the expression ofa number ofmolecules including MHC class II, CD40, and CD23, which may be involved in T and B cell interactions (35, (53) (54) (55) (56) (57) . Therefore, the ability of IL-4 to upregulate expression of some of these molecules may contribute to its capacity to promote T cell dependent B cell activation. Neonatal T cells are largely CD45RA+ naive T cells. Therefore, it was possible that anti-CD3 stimulation caused these cells to differentiate in vitro or that IL-4 enhanced this differentiation. Anti-CD3 stimulation of the neonatal T cells with or without IL-4 did not result in a significant decrease in CD45RA expression even after prolonged culture periods. As CD45RA-cells account for < 3% of the irradiated T cells utilized in the current cultures it is unlikely that this small number of CD45RA-cells accounted for the results presented since 1 x I04 adult memory T cells minimally support Ig production by adult B cells in this culture system (40) . These results support the conclusion that the T cell help in these cultures originated from CD45RA+ cells and that anti-CD3 stimulation with or without supplemental cytokines did not cause outgrowth of CD45RA-cells or differentiation of CD45RA+ cells to CD45RA-memory cells within the time frame of these experiments. These results are consistent with the demonstration by Clement et al. (39) that CD45RA+ cells were poor helper cells for adult B cells but demonstrate that they can provide help if maximally stimulated with anti-CD3 and supplemental cytokines are provided (39) .
IL-6 did not support Ig secretion in the presence of cyclosporin with or without IL-2. These results demonstrate important differences in the effects of IL-4 and IL-6 on neonatal Ig secretion. They also support the conclusion that IL-6 production is not necessary for all of the effects of IL-4, because IL-6 could not substitute for IL-4 in supporting Ig secretion in combination with IL-2 in cyclosporin-blocked cultures. It is also important to note that the combination of IL-6 and IL4 did not support Ig secretion in the presence ofcyclosporin suggesting that IL-6 does not induce Ig secretion in the absence of IL-2. The finding that IL-6 did not enhance Ig secretion in cyclosporin-blocked cultures supported by IL-2 or by IL-2 and IL-4 suggests that cyclosporin may inhibit the capacity of neonatal cells to respond to IL-6, or alternatively, IL-6 may indirectly increase Ig production by inducing the production of another cytokine. Additional experiments are currently examining these possibilities. The important conclusions from this study, however, are that although IL-6 can increase Ig production by neonatal lymphocytes, it cannot exert its effect in the absence of IL-2 and does not appear to be essential for the induction of Ig secretion.
In summary, anti-CD3-stimulated neonatal lymphocytes are deficient in their ability to produce IL-4 and IL-6. However, both ofthese cytokines are able to promote Ig secretion by anti-CD3-stimulated neonatal lymphocytes but neither appears to exert a specific effect on the pattern of Ig isotype secreted. IL-2 appears to be essential for Ig secretion by the neonatal B cells. IL-4 has major effects on T cell helper function including facilitation of cytokine production and possibly enhancement of the capacity to provide noncytokine signals required for B cell activation. IL-6 does not appear to be essential for neonatal Ig secretion but enhances Ig secretion in an IL-2-dependent manner. These results indicate that deficient cytokine production by neonatal lymphocytes is not coupled with inability to respond to supplemental cytokines and suggest approaches to enhance the primary humoral response of neonates.
